A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104.
about
Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastasesWhole brain radiotherapy for the treatment of multiple brain metastasesClinical practice guideline on the optimal radiotherapeutic management of brain metastasesMotexafin gadolinium in the treatment of brain metastasesRadiotherapy of brain metastases from breast cancer: Treatment results and prognostic factors.Cranial stereotactic radiosurgery: current status of the initial paradigm shifter.Defining the endpoints: how to measure the efficacy of drugs that are active against central nervous system metastases.Prognostic factors affecting the outcome of brain metastases from breast cancer.Concomitant treatment of brain metastasis with whole brain radiotherapy [WBRT] and temozolomide [TMZ] is active and improves quality of lifeWhole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems.DEGRO Practical Guidelines for palliative radiotherapy of breast cancer patients: brain metastases and leptomeningeal carcinomatosis.Current approaches to the treatment of metastatic brain tumours.Rationale for the use of upfront whole brain irradiation in patients with brain metastases from breast cancer.Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases.Randomized trial of erlotinib plus whole-brain radiotherapy for NSCLC patients with multiple brain metastasesThe impact of tumour histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients.A nomogram for individualized estimation of survival among patients with brain metastasisIncidence of hospitalization in patients receiving short course palliative cranial radiotherapy on outpatient basis in a limited resource setting - Experience from a regional cancer center in IndiaPalliative radiation therapy in the management of brain metastases, spinal cord compression, and bone metastasesSummary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastasesRisk factors of distant brain failure for patients with newly diagnosed brain metastases treated with stereotactic radiotherapy alone.Effectiveness of whole brain radiotherapy in the treatment of brain metastases: a systematic review.Current concepts and controversies in the treatment of parenchymal brain metastases: improved outcomes with aggressive management.Radiation dose-volume effects in the brain.Neuropsychological testing and biomarkers in the management of brain metastasesQuality of life in brain metastases radiation trials: a literature reviewCNS metastasis in primary breast cancer.Use of palliative radiotherapy trials for clinical biomarker development.Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline.CONCURRENT WHOLE BRAIN RADIOTHERAPY AND SHORT-COURSE CHLOROQUINE IN PATIENTS WITH BRAIN METASTASES: A PILOT TRIALPhase II clinical trial of whole-brain irradiation plus three-dimensional conformal boost with concurrent topotecan for brain metastases from lung cancerQuality of life and radiotherapy in brain metastasis patients.Radiotherapy for metastatic brain tumors.The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline.Whole-brain radiation therapy in breast cancer patients with brain metastases.Therapy and prophylaxis of brain metastases.Combining temozolomide with other antitumor drugs and target-based agents in the treatment of brain metastases: an unending quest or chasing a chimera?The role of whole brain radiation therapy for the management of brain metastases in the era of stereotactic radiosurgery.Management of brain metastasis: past lessons, modern management, and future considerations.Neurocognitive function impairment after whole brain radiotherapy for brain metastases: actual assessment.
P2860
Q24200466-36D1D728-913A-409F-98FA-12F95937F631Q24245002-81F25421-4D5D-4FDB-9F62-7415200DC8BEQ24798845-FA201637-477C-4274-96D9-57A388C6FFF3Q28285963-ABA9A0BA-71C3-4079-A3C3-31E1FEEAAC8BQ30315204-84BC26BA-24CC-4722-A764-5484A525857EQ30370889-3D1DC5AD-69BA-47C5-8B37-9CE4EA16EDF8Q31158877-9CFDEE52-7458-463B-B7C7-893DFAE61F4AQ33238114-43C0FB5B-1714-4A0C-A742-D1E3D5B0C9A0Q33270398-5F48DC1D-87B2-48AC-B906-41279EDC6C1AQ33280035-82C1F03D-6459-4EF2-9B13-3B1292F4F3CAQ33529158-C72F5385-239E-40CB-B748-8A3DD7734B7BQ33696559-8F715E51-FE57-4641-AF17-ACEDCCBCC711Q33755725-CCCC435E-0486-42BD-8D8B-8FDD6FB67A95Q33874796-BB860713-2715-429C-8C58-137A734F63CCQ33958338-278C37A0-6B40-4544-9452-51893A123846Q34054681-BB4C47E3-B149-4B78-8ABB-6C26C7C0664CQ34250819-A364C615-E24C-4AB2-B591-9C488A1A44A6Q34363629-15481E6A-05CE-4CE1-A8A5-F755E19625A1Q34566891-B10B3314-946D-4AC1-902E-2413C8170E15Q35721137-E36F6C77-C637-4AB1-84D7-04CA16063205Q35742324-471B5F98-0F74-4DA2-AC1E-074311F444F8Q36177515-F1135E50-8DCE-46FB-A689-17C1DC6B365CQ36229756-68BA57A8-04A4-48FD-B5AA-587B23E9F3EDQ36560171-46CADF0C-0E79-4CC2-8643-E7E98F057F6FQ36915247-32EC7AA9-73DD-4425-BF96-0835F0C0B76BQ36971728-C5FFE5D0-D6E6-4DF8-AF8C-D83BA23E8EBEQ37004668-D87F0108-C52D-4F5B-A442-067AD093F9D4Q37130199-55B87475-F4C1-44C9-AA5C-F09A67A16167Q37256355-862ADEFF-6527-4CE8-9CBB-53542FB5C5C1Q37262533-559A5703-3C05-44FA-91AD-593A035BC14FQ37368787-DD3C73F8-C894-496A-8EAA-26E9D88FF745Q37454266-F3ADA662-1F9B-414F-83F3-C7183439BEC6Q37586257-DD2494CF-851F-4386-94DE-F8B80B4757A7Q37644237-7896A72D-4759-4CE3-940D-1094152B2ACFQ37772075-AEA7FFE0-5846-4E03-8504-EDBBB62E9CEDQ37809862-9E91D6A0-31FF-4552-9D6D-4FF28215995AQ37870216-C630DCF7-118C-4A61-ADE5-CCE662AE37F6Q37946749-CC3D342D-4C87-458C-9A32-5208ABD76A2FQ37954518-29D3A58A-8400-4DE9-BECF-53B1D1AA7A88Q38013846-ECB054C8-C472-404D-B69F-2E1588DBAF75
P2860
A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
A randomized phase III study o ...... py Oncology Group (RTOG) 9104.
@en
type
label
A randomized phase III study o ...... py Oncology Group (RTOG) 9104.
@en
prefLabel
A randomized phase III study o ...... py Oncology Group (RTOG) 9104.
@en
P2093
P1476
A randomized phase III study o ...... py Oncology Group (RTOG) 9104.
@en
P2093
Greenberg HM
P304
P356
10.1016/S0360-3016(97)00341-6
P407
P577
1997-10-01T00:00:00Z